ArticleCureus2025
Malignant Progression Outcomes of Bosniak Graded Renal Cysts in the Modern Era of Better Imaging and Uro-Radiology Subspecialisation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective The Bosniak grading system is used to help clinicians manage renal cysts by predicting malignant potential; however, its limitations include variable reported malignancy rates, particularly in Class IIF. Initially, these cysts were predicted to have a malignant potential of 18.5% therefore, they are followed up for at least five years. The aim of this study was to provide the outcome of Bosniak graded cysts in the modern era of CT imaging and uro-radiology subspecialisation to assess the malignant potential of each class. Methods A total of 379 Bosniak graded cysts were analyzed over a five-year period, with a median follow-up of 11.2 months. Malignant potential was calculated based on radiological progression or histopathology. Results Subsequent malignant transformation rates were 0% in category 1, 1.70% in category 2, 3.96% in category 2F, 27.78% in category 3, and 61.54% in category 4. Conclusion This study adds to the growing body of evidence that Bosniak cysts, especially Class IIFs, are less malignant than previously thought. Stringent evaluation of these cysts in dedicated renal multidisciplinary teams (MDTs) is to be encouraged along with further research. This will contribute to a refinement of the follow-up guidelines to ensure they are both appropriate and safe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.